A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer

NCT02428270 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Adenocarcinoma

Interventions

DRUG: GSK2256098
DRUG: Trametinib

Sponsor

University Health Network, Toronto

Collaborators

[object Object]